文献速递姑息放疗与转移瘤

索引痛与非索引痛终点与疼痛干扰改善的关联:前瞻性观察研究的二次分析

Index and Nonindex Pain Endpoints in Radiation Therapy for Painful Tumors: A Secondary Analysis of a Prospective Observational Study.
PubMed 文献 · Adv Radiat Oncol · 2020-10-26

该研究基于302例接受姑息放疗的疼痛性肿瘤患者(127例骨转移,175例非骨转移),利用简明疼痛量表评估基线及治疗后2个月的疼痛干扰变化。结果显示索引痛缓解者的疼痛干扰评分下降幅度显著大于未缓解者,而存在其他疼痛为主(POP)的患者疼痛干扰改善较差;骨转移与非骨转移患者中上述关联无显著差异。

要点

  • 索引痛缓解与疼痛干扰改善正相关,非索引痛(POP)则与改善负相关。
  • 骨转移与非骨转移肿瘤患者中,疼痛终点与疼痛干扰的关联无 apparent 差异。
  • 评估姑息放疗疗效时需同时关注索引痛和非索引痛对日常活动干扰的影响。

核心结论

  • 索引痛缓解与疼痛干扰改善正相关,非索引痛(POP)与疼痛干扰改善负相关。
  • 骨转移与非骨转移肿瘤患者中,上述关联无 apparent 差异。

研究设计与样本

  • 前瞻性观察研究的二次分析,纳入302例接受姑息放疗的疼痛性肿瘤患者。
  • 127例(42%)为疼痛性骨转移(PBM),175例(58%)为疼痛性非骨转移肿瘤(PNT)。
  • 使用简明疼痛量表在基线及治疗后2个月评估疼痛干扰变化。

关键数值与推荐

  • 索引痛缓解采用国际共识终点评估。
  • POP定义为存在恶性或不明来源的非索引痛且疼痛评分高于索引痛。
  • 疼痛干扰评分基于7个子项条目的均值。

临床怎么用

  • 姑息放疗疗效评估应同时关注索引痛缓解和非索引痛(POP)情况。
  • 对存在POP的患者,需认识到其疼痛干扰改善可能较差。
  • 骨转移与非骨转移肿瘤患者可采用相似的疼痛终点评估疼痛干扰变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Improving pain interference in daily activities, rather than mere pain reduction, is a desirable endpoint for palliative radiation therapy. The association between pain response and pain interference has been studied almost exclusively in patients with painful bone metastases (PBMs), whereas nonindex pain has scarcely been explored in palliative radiation therapy. We investigated whether index and nonindex pain endpoints are associated with pain interference changes in patients with both PBMs and painful non-bone-metastasis tumors (PNTs). METHODS AND MATERIALS: Brief pain inventory data collected at baseline and at 2 months post-treatment were used to calculate differences in pain interference scores. Pain response in terms of the index pain was assessed using the international consensus endpoint. Patients were diagnosed with predominance of other pain (POP) if nonindex pain of malignant or unknown origin was present and had a greater pain score than the index pain. RESULTS: Of 302 patients, 127 (42%) had PBMs and 175 (58%) had PNTs. The median pain interference score, which is based on the mean of the 7 subscale items, decreased to a greater extent among responders than among nonresponders (PBM group: -3.43 vs -0.57 [P = .005]; PNT group: -2.43 vs -0.29 [P < .001]). Moreover, patients without POP experienced a greater reduction in their median pain interference score than did those with POP (PBM group: -2.71 vs +0.43 [P = .004]; PNT group: -2.00 vs +1.57 [P = .007]). The Jonckheere-Terpstra test showed a significant trend across 4 pain response categories in patients with PBMs and those with PNTs (P < .001 for both). CONCLUSIONS: The index and nonindex pain endpoints were positively and negatively associated with improvement in pain interference, respectively. There was no apparent difference between patients with PBMs and PNTs in terms of the associations of these endpoints with pain interference.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Saito T, Nakamura N, Murotani K, et al. Index and Nonindex Pain Endpoints in Radiation Therapy for Painful Tumors: A Secondary Analysis of a Prospective Observational Study. Adv Radiat Oncol. 2020. PMID: 33305072. doi:10.1016/j.adro.2020.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。